---
title: "SelectQuote Q2 revenue slightly beats estimates, 2026 guidance revised"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/274969912.md"
datetime: "2026-02-05T12:12:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274969912.md)
  - [en](https://longbridge.com/en/news/274969912.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274969912.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/274969912.md) | [繁體中文](https://longbridge.com/zh-HK/news/274969912.md)


# SelectQuote Q2 revenue slightly beats estimates, 2026 guidance revised

)

Overview

-   Insurance comparison platform’s Q2 revenue of $537.1 mln slightly beat analyst expectations
-   Net income for Q2 increased to $69.3 mln from $53.2 mln yr/yr
-   Q2 adjusted EBITDA decreased to $84.7 mln from $87.5 mln yr/yr

Outlook

-   Fiscal 2026 guidance impacted by a national carrier’s decision to limit MA policy volume and PBM reimbursement changes
-   SelectQuote projects fiscal year 2026 revenue between $1.61 bln and $1.71 bln
-   SelectQuote expects fiscal year 2026 adjusted EBITDA between $90 mln and $100 mln
-   Company cites partner-driven headwinds impacting fiscal 2026 guidance

Result Drivers

-   SENIOR SEGMENT - Stable revenue and adjusted EBITDA margins despite volatility in Medicare Advantage benefits, highlighting strong execution
-   HEALTHCARE SERVICES GROWTH - Significant revenue and membership growth in Healthcare Services, driven by SelectRx

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Slight $537.10 $534.30

Revenue Beat\* mln mln (3

Analysts

)

Q2 Net $69.30

Income mln

### Q2 $84.70

Adjusted mln

### EBITDA

\*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

-   The current average analyst rating on the shares is “buy” and the breakdown of recommendations is 2 “strong buy” or “buy”, 2 “hold” and no “sell” or “strong sell”
-   The average consensus recommendation for the multiline insurance & brokers peer group is “buy”
-   Wall Street’s median 12-month price target for SelectQuote Inc is $4.50, about 210.3% above its February 4 closing price of $1.45

Press Release: For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact . (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

### 相关股票

- [Selectquote (SLQT.US)](https://longbridge.com/zh-CN/quote/SLQT.US.md)

## 相关资讯与研究

- [SelectQuote, Inc. SEC 10-Q Report](https://longbridge.com/zh-CN/news/274988785.md)
- [SelectQuote Inc. to Release Fiscal Second Quarter 2026 Earnings](https://longbridge.com/zh-CN/news/273368610.md)
- [SelectQuote Q2 net income rises to USD 69.3 million, up 30%](https://longbridge.com/zh-CN/news/274968100.md)
- [SelectQuote meldet für das zweite Quartal einen Nettogewinn von 69,3 Mio. USD, plus 30 Prozent](https://longbridge.com/zh-CN/news/274968170.md)
- [SelectQuote Signs Multiyear Agreement With Longtime PBM Partner](https://longbridge.com/zh-CN/news/272692709.md)